REG - Deutsche Bank AG FF - Post Stabilisation Notice - Fresenius Medical Care
RNS Number : 7068QDeutsche Bank AG, Frankfurt22 June 202022-Jun-20
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in
which such distribution would be unlawful.
Fresenius Medical Care AG & Co KGaA
Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 19/05/201 Deutsche Bank AG (contact: DCM Syndication TA; telephone: 0207 54 54153 hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority)2 was undertaken by the Stabilisation Manager(s)3 named below in relation to the offer of the following securities.
The Securities:
Issuer: Fresenius Medical Care AG & Co KGaA
Guarantor (if any): Fresenius Medical Care Holdings, Inc.
Aggregate nominal amount: EUR 1.25 Billion
Description: Fresenius Medical Care 6yr & 10yr EUR1.25bn dual-tranche
Stabilisation Manager(s): Commerzbank, Deutsche Bank, Mizuho, Societe Generale
Offer Price: 99.405% / 99.742%
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDSTAEASKAASNEEFA